FILTER

Refine your search with the following facets to narrow down your results.

7 Current news of Enigma Diagnostics

Tecan and Enigma Diagnostics sign global manufacturing and supply agreement for point-of-care Molecular Diagnostics instruments

08-Feb-2010 - The Tecan Group and Enigma Diagnostics Limited announced the signing of a manufacturing and supply agreement for Enigma's ML instruments. Under the agreement, Tecan will industrialize and deliver commercially manufactured ML instruments for Enigma's global market supplies for an initial five-year ...

molecular diagnostics services Tecan

Enigma Diagnostics Expands Its US and European Executive Management Teams

30-Nov-2009 - Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced four senior appointments for its US and European offices. Dr. Jorge Garces will lead the US team as President and CEO with Greg Hamilton, Chief Operating Officer and Chief Financial Officer, ...

biochemistry clinical trials cystic fibrosis +7

Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.

21-Jul-2009 - Enigma Diagnostics Limited announced that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on15 July 2009, provide Enigma full access under patents owned or licensed by RMS and its affiliates to practice HybProbe real-time PCR chemistry ...

Celera diagnostics infectious diseases +6

Enigma Diagnostics Announces Patent Licence With Applied Biosystems

27-Oct-2008 - Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems. The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence ...

acids Applied Biosystems patents +1

Enigma sign real-time PCR license with Applera

11-Feb-2008 - Enigma Diagnostics announced that it has signed license agreements with Applera Corporation. The licenses, signed 6 February 2008, include a Real-Time Instrument Patent License Agreement and an Application Kit License Agreement. These agreements provide Enigma with access under patents owned or ...

Applera diagnostics license agreements +2

Enigma Diagnostics signs exclusive licence agreement with the UK Defence Science and Technology Laboratory

24-Aug-2007 - Enigma Diagnostics announced that it has signed a new exclusive licence agreement with the Defence Science and Technology Laboratory (Dstl). The worldwide licence covers a broad range of technologies, including Pyrostart, ResonSense and Temperature Control, which are important elements of ...

bacteria patents PCR +3

Enigma Diagnostics appoints Professor Christopher Lowe as non-executive director

22-Dec-2006 - Enigma Diagnostics, a life sciences company developing rapid molecular diagnostics systems, announced the appointment of Professor Christopher Lowe as Non-executive Director. Professor Lowe is Director of the Institute of Biotechnology at the University of Cambridge. He is a Fellow of the Royal ...

biochemistry biotechnology chemical engineering +7